Your trusted destination for CME, CPD & Medical Education across the Middle East.
The Egyptian Society of Hemato-Oncology and Bone Marrow Transplantation Conference provides an educational platform for specialists to explore evolving practices in hemato-oncology and stem cell transplantation. It combines expert-led scientific sessions and clinical discussions to help healthcare professionals stay informed about emerging treatments, transplantation approaches, and advances in the management of hematological diseases.
The Egyptian Society of Hemato-Oncology and Bone Marrow Transplantation Conference is a specialized medical meeting focused on the latest advances in hematologic malignancies, hemato-oncology, and bone marrow transplantation. The conference brings together hematologists, oncologists, transplant physicians, researchers, and allied healthcare professionals to exchange knowledge and clinical experience. Scientific sessions explore contemporary approaches to the diagnosis, treatment, and monitoring of blood cancers and other complex hematological conditions. Key discussions may cover transplantation strategies, cellular therapies, targeted treatments, immunotherapy, supportive care, and emerging therapeutic options. The program provides opportunities to examine recent clinical evidence and developments that can influence patient management and treatment outcomes. Interactive scientific discussions also encourage collaboration and knowledge sharing among specialists from Egypt and the wider regional medical community. By highlighting innovations in hemato-oncology and transplantation, the conference supports continuous professional development and advances in multidisciplinary patient care.
Recent advances in the diagnosis, classification, and treatment of acute and chronic leukemias and lymphomas.
Exploring novel therapeutic agents, combination therapies, and long-term management strategies for multiple myeloma.
Evaluating patient selection, conditioning regimens, and survival outcomes for autologous and allogeneic transplants.
Latest protocols for the prophylaxis, early detection, and management of acute and chronic GVHD.
Clinical applications, efficacy, and management of toxicities associated with CAR T-cell therapies in blood cancers.
The role of targeted therapies and monoclonal antibodies in improving progression-free survival in hemato-oncology.
Advances in systemic and targeted therapies.
New drug combinations, immunotherapies and treatment strategies.
| Applications of monoclonal antibodies, bispecific antibodies and cellular therapies. |
| Modern management of myelofibrosis, polycythemia vera and essential thrombocythemia. |
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow